#term loan facility

Alvotech, a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, amended its existing credit agreement with funds managed by GoldenTree Asset Management and other existing lender

Dyne Therapeutics, a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, entered into an amendment to its non-dilutive senior secured term loan facility with Hercules C

Market intelligenceInteractive platform The full data platform with the latest numbers, analysis and market report is free for EHPA members – log in below! If you are not a member you can subscribe for full data access or use the free platform. If yo